跳至主要内容
临床试验/NCT06212947
NCT06212947招募中不适用

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

BioMarin Pharmaceutical43 个研究点 分布在 11 个国家目标入组 400 人开始时间: 2023年11月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
43
主要终点
Change in BMI

研究概览

简要总结

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Participants must be ≤ 15 years old at the time of signing the informed consent
  • Participants must have genetic confirmation of Hypochondroplasia diagnosis

排除标准

  • Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
  • Received an investigational product or medical device within 6 months before the Screening visit

结局指标

主要结局

Change in BMI

时间窗: Every 6 months through end of study, up to 15 years

Change in ratios of upper to lower body segments

时间窗: Every 6 months through end of study, up to 15 years

Change in Height

时间窗: Every 6 months through end of study, up to 15 years

Change in Height Z-score

时间窗: Every 6 months through end of study, up to 15 years

Change in BMI Z-score

时间窗: Every 6 months through end of study, up to 15 years

Change in ratios of upper and lower leg length ratio

时间窗: Every 6 months through end of study, up to 15 years

Change in annualized growth velocity (AGV)

时间窗: Every 6 months through end of study, up to 15 years

Change in ratio of arms span to standing height ratio

时间窗: Every 6 months through end of study, up to 15 years

次要结局

  • Change in patient global impression of severity (PGI-S)(Every 52 weeks through end of study, up to 15 years)
  • Change in caregiver global impression of severity (CaGI-S)(Every 52 weeks through end of study, up to 15 years)
  • Change in Quality of Life in Short Statured Youth (QoLISSY) physical domain(Every 52 weeks through end of study, up to 15 years)
  • Proportion of children who report use of growth hormone, treatment patterns and impact on growth(Every 6 months through end of study, up to 15 years)
  • Frequency of event rates of medical events of interest(Every 6 months through end of study, up to 15 years)
  • Proportion of children who report limb lengthening surgery(Every 6 months through end of study, up to 15 years)
  • Change in Quality of Life in Short Statured Youth (QoLISSY) total score(Every 52 weeks through end of study, up to 15 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (43)

Loading locations...

相似试验